Share-based Compensation (Tables)

12 Months Ended

Jun. 30, 2022

Share-based Compensation

Schedule of weighted average assumptions

	2021			2020
Risk-free interest rate		0.2	%		1.9	%
Expected volatility		82.5	%		73.7	%
Expected dividend yield		—	%		—	%
Forfeiture rate		—	%		—	%
Expected term		5.0	years		5.1	years
Weighted average fair value	$	3.86		$	4.00

Summary of stock option award activity

						Weighted
		Weighted-				Average
		Average		Aggregate		Remaining
		Exercise		Intrinsic		Contractual
(In thousands, except for weighted average price and life data)	Awards	Price		Value		Life (yrs.)
Outstanding at June 30, 2019	572	$	17.56	$	273	5.0
Granted	522	$	6.57
Exercised	(56)	$	5.42	$	237
Forfeited, expired or repurchased	(47)	$	24.73
Outstanding at June 30, 2020	991	$	12.11	$	678	5.6
Granted	309	$	5.95
Exercised	(37)	$	4.12	$	61
Forfeited, expired or repurchased	(217)	$	17.17
Outstanding at June 30, 2021	1,046	$	9.51	$	25	7.2
Exercised	(3)	$	3.55	$	2
Forfeited, expired or repurchased	(108)	$	14.63
Outstanding at June 30, 2022	935	$	8.94	$	—	6.5
Vested and expected to vest at June 30, 2022	935	$	8.94	$	—	6.5
Exercisable at June 30, 2022	530	$	10.98	$	—	5.6

Summary of non-vested restricted stock awards

		Weighted
		Average Grant-date		Aggregate
(In thousands, except for weighted average price data)	Awards	Fair Value		Intrinsic Value
Non-vested at June 30, 2019	1,288	$	11.63
Granted	941		6.45
Vested	(773)		10.54	$	6,401
Forfeited	(112)		10.75
Non-vested at June 30, 2020	1,344	$	8.70
Granted	901		5.74
Vested	(805)		8.60	$	4,668
Forfeited	(90)		9.18
Non-vested at June 30, 2021	1,350	$	6.75
Granted	1,110		4.14
Vested	(1,002)		5.97	$	3,789
Forfeited	(103)		5.54
Non-vested at June 30, 2022	1,355	$	5.28

Schedule of non-vested performance-based shares

		Weighted
		Average Grant-date
(In thousands, except for weighted average price and life data)	Awards	Fair Value
Non-vested at June 30, 2019	72	$	19.92
Granted	178		10.71
Vested	(46)		15.08
Non-vested at June 30, 2020	204	$	12.99
Granted	339		9.22
Performance adjustment (1)	(12)		25.58
Non-vested at June 30, 2021	531	$	10.29
Granted	617		6.04
Performance adjustment (2)	(40)		17.69
Vested	(58)		7.72
Non-vested at June 30, 2022	1,050	$	7.65

________________________________________

(1) Represents the adjustment based on the performance of the September 2017 awards, which was below the Threshold goal level resulting in no shares vesting at the end of the three-year performance period.

(2) Represents the adjustment based on the performance of the July 2018 awards, which was below the Threshold goal level resulting in no shares vesting at the end of the three-year performance period.

Schedule of allocation of share-based compensation

	For Fiscal Year Ended June 30,
(In thousands)	2022		2021		2020
Selling, general and administrative expenses	$	7,536	$	7,016	$	7,087
Research and development expenses		181		538		801
Cost of sales		693		1,483		2,328
Total	$	8,410	$	9,037	$	10,216
Tax benefit at statutory rate	$	1,892	$	2,033	$	2,299